Marx, S. J., & Sinaii, N. (2020). SUN-366 Neonatal Severe Hyperparathyroidism: Extreme Hypercalcemia as a Robust Marker for Homozygous Dosage of Pathogenic CASR Variants. J Endocr Soc.
Dyfyniad Arddull ChicagoMarx, Stephen J., and Ninet Sinaii. "SUN-366 Neonatal Severe Hyperparathyroidism: Extreme Hypercalcemia As a Robust Marker for Homozygous Dosage of Pathogenic CASR Variants." J Endocr Soc 2020.
Dyfyniad MLAMarx, Stephen J., and Ninet Sinaii. "SUN-366 Neonatal Severe Hyperparathyroidism: Extreme Hypercalcemia As a Robust Marker for Homozygous Dosage of Pathogenic CASR Variants." J Endocr Soc 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.